March 1, 2017 / 9:31 PM / 5 months ago

BRIEF-Pdl Biopharma qtrly loss per share $0.06

1 Min Read

March 2 (Reuters) - Pdl Biopharma Inc

* Board of directors has authorized repurchase of up to $30 million of company's common stock through march 2018

* Pdl biopharma announces fourth quarter and year end 2016 financial results

* Q4 revenue $66.5 million

* Qtrly loss per share $0.06 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below